Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
GH-21 by HUYA Bioscience International for Solid Tumor: Likelihood of Approval
GH-21 is under clinical development by HUYA Bioscience International and currently in Phase I for Solid Tumor. According to GlobalData,...
GH-21 by HUYA Bioscience International for Head And Neck Squamous Cell Carcinoma (HNSC): Likelihood of Approval
GH-21 is under clinical development by HUYA Bioscience International and currently in Phase I for Head And Neck Squamous Cell...
GH-21 by HUYA Bioscience International for Non-Small Cell Lung Cancer: Likelihood of Approval
GH-21 is under clinical development by HUYA Bioscience International and currently in Phase I for Non-Small Cell Lung Cancer. According...